Opthea (OPT) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free OPT Stock Alerts $3.64 +0.21 (+6.12%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOpthea to Present at the OIS Retina Innovation Summit at ARVOglobenewswire.com - April 25 at 9:00 AMAnalyzing Opthea (NASDAQ:OPT) & Cellectis (NASDAQ:CLLS)americanbankingnews.com - April 23 at 1:44 AMLeerink Partnrs Research Analysts Decrease Earnings Estimates for Opthea Limited (NASDAQ:OPT)marketbeat.com - April 12 at 6:40 AMOpthea Appoints John Han, PharmD, as VP Medical Affairsglobenewswire.com - April 8 at 6:42 PMOpthea Limited American Depositary Shares (OPT)nasdaq.com - April 5 at 1:37 PMOpthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 4 at 6:34 PMWhy A2 Milk, Lindsay Australia, Meridian Energy, and Opthea shares are falling todaymsn.com - April 3 at 11:14 PMOpthea Appoints Sujal Shah to the Board of Directorsglobenewswire.com - April 3 at 5:39 PM7 Growth Stocks to Buy to Outperform the Nasdaq Indexinvestorplace.com - April 3 at 9:53 AMOpthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024globenewswire.com - March 19 at 6:00 AMShort Interest in Opthea Limited (NASDAQ:OPT) Decreases By 21.1%marketbeat.com - March 14 at 12:47 PMEnd in sight as Opthea looks to be key player in US$10 billion wet AMD marketmsn.com - March 6 at 6:43 PMOpthea to Participate in the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 5 at 5:08 PMOpthea Reports Half-Year Financial Results and Business Updatesglobenewswire.com - February 28 at 5:55 PMOpthea Limited (OPT)au.finance.yahoo.com - February 22 at 3:16 PMOpthea Limited: Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisorfinanznachrichten.de - February 20 at 5:31 AMOpthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisorglobenewswire.com - February 19 at 6:25 PMOpthea Limited (NASDAQ:OPT) Short Interest Up 8.2% in Januarymarketbeat.com - February 17 at 8:31 AMOpthea Limited: Opthea Completes Enrollment in First Pivotal Trial with Soziniberceptfinanznachrichten.de - February 14 at 10:23 AMOpthea Completes Enrollment in First Pivotal Trial with Soziniberceptfinance.yahoo.com - February 14 at 10:23 AMOpthea Completes Enrollment in First Pivotal Trial with Soziniberceptglobenewswire.com - February 14 at 7:00 AMOpthea Limited (NASDAQ:OPT) Expected to Post FY2027 Earnings of $0.00 Per Sharemarketbeat.com - January 31 at 7:50 AMShort Interest in Opthea Limited (NASDAQ:OPT) Rises By 70.4%marketbeat.com - January 12 at 10:39 PMWhy Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?msn.com - December 27 at 12:28 PMOpthea to receive $35M commitment and additional $50M fundingmsn.com - December 27 at 7:28 AMOpthea Limited ADRs Rise 31% on Raised Fundingmarketwatch.com - December 27 at 7:28 AMOpthea to Receive US$35M Commitment and Additional US$50M Fundingfinance.yahoo.com - December 27 at 7:28 AMOpthea Limited - ADR (OPT) Price Target Increased by 7.41% to 6.39msn.com - December 16 at 2:18 PMOpthea to Present at the FLORetina 2023 Congressfinance.yahoo.com - December 1 at 9:30 AMOpthea Limited - ADR (OPT) Price Target Increased by 9.06% to 5.95msn.com - November 27 at 7:04 PMOpthea to Present at the Jefferies 2023 London Healthcare Conferencefinance.yahoo.com - November 9 at 7:56 AMOpthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conferencefinance.yahoo.com - October 30 at 6:59 AMOpthea appoints U.S.-based leadership with Fred Guerard as CEOmsn.com - October 27 at 9:27 AMOpthea Limited (ASX:OPT) is definitely on the radar of institutional investors who own 38% of the companyfinance.yahoo.com - October 25 at 7:30 PMmarketbeat.com - October 25 at 6:04 AMOppenheimer Lowers Opthea (NASDAQ:OPT) Price Target to $16.00marketbeat.com - September 13 at 10:14 AMOpthea to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 5:51 AMmarketbeat.com - August 24 at 6:01 AMCarlyle goes all in on biotech Opthea; MST launches $80m capital raiseafr.com - August 23 at 10:16 PMVictory Capital Management Inc. Sells 50,429 Shares of Opthea Limited (NASDAQ:OPT)marketbeat.com - August 3 at 4:47 AMH.C. Wainwright Remains a Buy on Opthea Limited Sponsored ADR (OPT)markets.businessinsider.com - August 1 at 8:05 PMOpthea to Present at the 2023 Ophthalmology Innovation Summitfinance.yahoo.com - July 24 at 7:15 AMOpthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisorfinance.yahoo.com - July 10 at 8:39 AMOpthea (NASDAQ: OPT)fool.com - June 11 at 10:12 AMOpthea to Present at the Jefferies 2023 Healthcare Conferencefinance.yahoo.com - May 25 at 8:16 AMOptiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence Awardsfinance.yahoo.com - May 25 at 8:16 AMOpthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Marketfinance.yahoo.com - May 17 at 8:31 AMOPTHEA (ASX:OPT) Price Target Increased by 319.45% to 7.06msn.com - May 12 at 7:40 AMOpthea Stock (NASDAQ:OPT), Dividendsbenzinga.com - March 17 at 11:13 PMOpthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conferencefinance.yahoo.com - March 6 at 7:37 AM Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. OPT Media Mentions By Week OPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.000.41▲Average Medical News Sentiment OPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼20▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRDF News KOD News IPHA News IPSC News ABOS News ELEV News CMPX News PSTX News XFOR News GRPH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
